Find out about some of the wide-ranging types of studies available via the Join Dementia Research service.
Online studies open!
24 August 2021
Did you know that many of the studies on Join Dementia Research are open to anyone over 18 without a dementia diagnosis? These tend to be online studies, which can be done at home, at a time to suit you. Because these studies are keen to attract a large number of people they run for […]
16 August 2021
The beneficial aspects of listening to music such as calming anxiety, reducing stress and inducing a relaxing effect, are being tested in a new study for people living with dementia. The context As well as experiencing cognitive decline, people with dementia often also suffer from ‘neuropsychiatric symptoms’ such as depression, irritability, anxiety and hallucinations. In […]
PRESIDE A singing study!
12 May 2021
It is well documented that music and singing are beneficial to those living with dementia. Listening to or singing songs can provide both behavioural and emotional benefits and the power of music can unlock memories and help provide links to a person’s past and promote connection with carers. Researchers at Nottingham University are looking for […]
Exploring the relationship between Lewy body dementia and delirium
19 April 2021
Lewy body dementia (LBD) is one of the most common forms of dementia. The symptoms of LBD can affect a variety of brain functions including; thinking, attention, sleeping and perception. It is often difficult to diagnose and can appear similar to other medical issues such as delirium. Researchers at the University of Cambridge are looking […]
Study into making financial services dementia-friendly
23 March 2021
Dementia can impair the ability of the individual to manage their financial affairs. This means that they will require support from family members in ensuring good financial outcomes and protection. Often those living with dementia enter into a power of attorney agreement that empowers a named person to act on their behalf and assist them […]
New potential treatment for early-stage Alzheimer’s disease
3 March 2021
Alzheimer’s disease affects approximately 70% of people diagnosed with dementia, and an estimated 26 million people worldwide. In the very early stages, Alzheimer’s disease may be referred to or diagnosed as Mild Cognitive Impairment (MCI). There are no available treatments to prevent or delay the start of Alzheimer’s disease and currently medications only provide a […]
Can remotely delivered real-time health coaching improve cognition?
1 February 2021
As we get older we tend to spend more time being inactive – up to 60% of older people report sitting for more than four hours per day. The positive impacts of exercise on our physical health are well known, but researchers at Anglia Ruskin University are looking into whether remotely delivered coaching aimed at […]
Adjusting dementia support studies in response to the COVID-19 pandemic
14 January 2021
Certain Join Dementia Research studies have adapted to an online offer so that researchers can continue to gain important insights, and ultimately help to support those living with dementia during the COVID-19 pandemic. Beyond the margins Researchers at Durham University, the University of Edinburgh and their partners Innovations in Dementia are developing and testing a […]
Study aims to support independence at home for people with dementia
14 December 2020
Most people with dementia want to remain living in their own homes for as long as they can, this can be made possible through either paid or family carers. However, lack of dementia training for paid carers can cause the relationships to break down. For family carers, problems with behaviour and communication can often cause […]
Alzheimer’s drug study restarts
23 November 2020
An Alzheimer’s drug study is restarting after being paused earlier this year. The CLARITY study is examining whether the drug BAN2401 can be effective in preventing or delaying the very early stages of Alzheimer’s disease. Alzheimer’s disease affects approximately 26 million people worldwide and current medications only provide a temporary improvement in symptoms. Who can […]